Evidence map›Paper›PMID 29765412›Full record

ArticleStem cells international2018

Neural Stem Cell-Conditioned Medium Ameliorated Cerebral Ischemia-Reperfusion Injury in Rats.

HongNa Yang, Cuilan Wang, Hui Chen, Lan Li, Shuang Ma, Hao Wang, YaRu Fu, Tingyu Qu

Open access · goldAbstract read
In one paragraph

Article in Stem cells international, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Neural stem cell conditioned medium alleviates AβEuropean journal of histochemistry : EJH · 2020
    Article
  20. Therapeutic Plasticity of Neural Stem Cells.Frontiers in neurology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

HongNa YangDepartment of Critical Care Medicine, Qilu Hospital of Shandong University, Shandong University, Jinan, Shandong 250012, China.ORCID 0000-0001-7573-5325
Cuilan WangDepartment of Neurology, Qilu Hospital of Shandong University, Shandong University, Jinan, Shandong 250012, China.
Hui ChenDepartment of Neurology, Qilu Hospital of Shandong University, Shandong University, Jinan, Shandong 250012, China.
Lan LiDepartment of Neurology, Qilu Hospital of Shandong University, Shandong University, Jinan, Shandong 250012, China.
Shuang MaDepartment of Neurology, Qilu Hospital of Shandong University, Shandong University, Jinan, Shandong 250012, China.
Hao WangDepartment of Critical Care Medicine, Qilu Hospital of Shandong University, Shandong University, Jinan, Shandong 250012, China.
YaRu FuR & D of Cell and Tissue Bank, Qilu Stem Cell Engineering Company of Shandong Province, Jinan, Shandong 250000, China.
Tingyu QuDepartment of Psychiatry, University of Illinois College of Medicine, 1601 West Taylor Street, Chicago, IL 60612, USA.ORCID 0000-0002-4818-8538
Qilu Hospital of Shandong University · CNCell Technology (China) · CNIllinois College · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionOur previous study suggested that NSC-CM (neural stem cell-conditioned medium) inhibited cell apoptosis

methodsAdult male Sprague-Dawley rats receiving middle cerebral artery occlusion surgery as an animal model of cerebral I/R injury were randomly assigned to two groups: the control group and NSC-CM-treated group. 1.5 ml NSC-CM or PBS (phosphate buffer saline) was administrated slowly by tail vein at 3 h, 24 h, and 48 h after ischemia onset.

resultsNSC-CM significantly ameliorated neurological defects and reduced cerebral infarct volume, accompanied by preserved mitochondrial ultrastructure. In addition, we also found that NSC-CM significantly inhibited cell apoptosis in the ischemic hemisphere via improving the expression of Bcl-2 (B-cell lymphoma-2).

conclusionNSC-CM might be an alternative and effective therapeutic intervention for ischemic stroke.

Identifiers

PMID29765412
PMCPMC5903322
OpenAlexW2795414523

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.